188 related articles for article (PubMed ID: 20732651)
1. Prospects for gene therapy in inflammatory arthritis.
Jorgensen C; Apparailly F
Best Pract Res Clin Rheumatol; 2010 Aug; 24(4):541-52. PubMed ID: 20732651
[TBL] [Abstract][Full Text] [Related]
2. Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis.
Schiffelers RM; Xu J; Storm G; Woodle MC; Scaria PV
Arthritis Rheum; 2005 Apr; 52(4):1314-8. PubMed ID: 15818667
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus type 5-mediated intraarticular administration of tumor necrosis factor small interfering RNA improves collagen-induced arthritis.
Khoury M; Courties G; Fabre S; Bouffi C; Seemayer CA; Vervoordeldonk MJ; Tak PP; Jorgensen C; Apparailly F
Arthritis Rheum; 2010 Mar; 62(3):765-70. PubMed ID: 20187132
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic silencing of an endogenous gene by siRNA cream in an arthritis model mouse.
Takanashi M; Oikawa K; Sudo K; Tanaka M; Fujita K; Ishikawa A; Nakae S; Kaspar RL; Matsuzaki M; Kudo M; Kuroda M
Gene Ther; 2009 Aug; 16(8):982-9. PubMed ID: 19474812
[TBL] [Abstract][Full Text] [Related]
5. Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy.
Adriaansen J; Tas SW; Klarenbeek PL; Bakker AC; Apparailly F; Firestein GS; Jorgensen C; Vervoordeldonk MJ; Tak PP
Ann Rheum Dis; 2005 Dec; 64(12):1677-84. PubMed ID: 15878906
[TBL] [Abstract][Full Text] [Related]
6. Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes.
Khoury M; Escriou V; Courties G; Galy A; Yao R; Largeau C; Scherman D; Jorgensen C; Apparailly F
Arthritis Rheum; 2008 Aug; 58(8):2356-67. PubMed ID: 18668557
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy in rheumatic diseases.
Vervoordeldonk MJ; Tak PP
Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):771-88. PubMed ID: 11812021
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: innovative vectors and therapeutic genes.
Adriaansen J; Vervoordeldonk MJ; Tak PP
Rheumatology (Oxford); 2006 Jun; 45(6):656-68. PubMed ID: 16510530
[TBL] [Abstract][Full Text] [Related]
9. Short interfering RNA (siRNA): tool or therapeutic?
Cejka D; Losert D; Wacheck V
Clin Sci (Lond); 2006 Jan; 110(1):47-58. PubMed ID: 16336204
[TBL] [Abstract][Full Text] [Related]
10. RNA interference for therapy in the vascular endothelium.
Kaufmann J; Ahrens K; Santel A
Microvasc Res; 2010 Sep; 80(2):286-93. PubMed ID: 20144624
[TBL] [Abstract][Full Text] [Related]
11. Inflammation-inducible anti-TNF gene expression mediated by intra-articular injection of serotype 5 adeno-associated virus reduces arthritis.
Khoury M; Adriaansen J; Vervoordeldonk MJ; Gould D; Chernajovsky Y; Bigey P; Bloquel C; Scherman D; Tak PP; Jorgensen C; Apparailly F
J Gene Med; 2007 Jul; 9(7):596-604. PubMed ID: 17514770
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 receptor antagonist gene therapy for arthritis.
Krishnan BR
Curr Opin Mol Ther; 1999 Aug; 1(4):454-7. PubMed ID: 11713759
[TBL] [Abstract][Full Text] [Related]
13. Technology insight: gene transfer and the design of novel treatments for rheumatoid arthritis.
Moritz F; Distler O; Ospelt C; Gay RE; Gay S
Nat Clin Pract Rheumatol; 2006 Mar; 2(3):153-62. PubMed ID: 16932675
[TBL] [Abstract][Full Text] [Related]
14. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
[TBL] [Abstract][Full Text] [Related]
15. Intra-articular lentivirus-mediated delivery of galectin-3 shRNA and galectin-1 gene ameliorates collagen-induced arthritis.
Wang CR; Shiau AL; Chen SY; Cheng ZS; Li YT; Lee CH; Yo YT; Lo CW; Lin YS; Juan HY; Chen YL; Wu CL
Gene Ther; 2010 Oct; 17(10):1225-33. PubMed ID: 20520649
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of RNA interference against cancer.
Takeshita F; Ochiya T
Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
[TBL] [Abstract][Full Text] [Related]
17. Developing the concept of adoptive cellular gene therapy of rheumatoid arthritis.
Tarner IH; Neumann E; Gay S; Fathman CG; Müller-Ladner U
Autoimmun Rev; 2006 Feb; 5(2):148-52. PubMed ID: 16431349
[TBL] [Abstract][Full Text] [Related]
18. RNAi in arthritis: prospects of a future antisense therapy in inflammation.
Khoury M; Jorgensen C; Apparailly F
Curr Opin Mol Ther; 2007 Oct; 9(5):483-9. PubMed ID: 17932812
[TBL] [Abstract][Full Text] [Related]
19. Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.
Hur W; Cho ML; Yoon SK; Kim SY; Ju JH; Jhun JY; Heo SB; Moon YM; Min SY; Park SH; Kim HY
Immunol Lett; 2006 Aug; 106(2):154-62. PubMed ID: 16793145
[TBL] [Abstract][Full Text] [Related]
20. Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis.
Terzioglu E; Bisgin A; Sanlioglu AD; Ulker M; Yazisiz V; Tuzuner S; Sanlioglu S
Rheumatology (Oxford); 2007 May; 46(5):783-9. PubMed ID: 17309888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
